UnitedHealth Group's $12.8 billion purchase of Catamaran makes sense

UnitedHealth Group's announcement that its free-standing pharmacy care services business, OptumRx, will merge with Catamaran Corp., the fourth largest pharmacy benefit manager in the U.S., makes sense, according to industry experts. » Details

Qatar International Medical Conference, May 26-28
At The Heart of Healthcare More.

The risks and rewards of Medical Loss Ratio

Given the fraud that has occurred with Medicaid managed care plans, executives for Medicare managed plans would benefit from knowing the challenges of using Medical Loss Ratio. » Learn more

Idiopathic Pulmonary Fibrosis (IPF)
IPF is the progressive formation of thick or scarred tissue in the lungs, resulting in loss of oxygen. While there is currently no known cause, continued research seeks to find an answer, alongside improved diagnosis and treatment options. Learn more.

BioCryst receives $12 million to develop Ebola drug

BioCryst Pharmaceuticals of Durham, North Carolina has received $12 million from the U.S. government for the advanced development of a promising experimental drug for Ebola. » Highlights

Keep in touch with MHE

We value your input. Please send your comments and article ideas to [email protected].